Vanderbilt-Ingram Cancer Center
-
August 29, 2022
Blood cancer progression
Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs. -
August 25, 2022
New high-tech biobank safeguards critical specimens
-
August 25, 2022
V Foundation support
Shane Jacobson, chief executive officer of the V Foundation for Cancer Research, on left, visited Vanderbilt-Ingram Cancer Center on Monday to meet with former and current recipients of funding from the foundation. -
August 18, 2022
Abramson, Eng, Johnson named to new VICC roles
Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles. -
August 17, 2022
Trial for colorectal cancer drug reaches primary endpoint
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial. -
August 11, 2022
Cell-free breast cancer “biopsy”
The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer. -
August 11, 2022
Couple’s gift helps support immunotherapy research
Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.